Arcellx Stock Earns 82 Relative Strength Rating

Blockhead

2024-12-28

Arcellx (ACLX) stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 79 to 82.

↑ X

This Is How A New President Will Impact Fed Rate Cuts In 2025

See All Videos

NOW PLAYING This Is How A New President Will Impact Fed Rate Cuts In 2025

This exclusive rating from Investor's Business Daily identifies share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.

Decades of market research shows that the market's biggest winners typically have an 80 or higher RS Rating in the early stages of their moves.

Hone Your Stock-Picking Skills By Focusing On These Factors

Is Arcellx Stock A Buy?

Arcellx stock is now considered extended and out of buy range after clearing a 74.09 buy point in a fourth-stage cup with handle. See if the biotech stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.

The Calif.-based biotech company reported 0% earnings growth in the latest quarterly report, while sales growth came in at 74%.

Arcellx stock holds the No. 111 rank among its peers in the Medical-Biomed/Biotech industry group. Catalyst Pharmaceuticals (CPRX), ADMA Biologics (ADMA) and Exelixis (EXEL) are among the top 5 highly rated stocks within the group. For more industry news, check out "Biotech And Pharmaceutical Industry And Stock News."

YOU MAY ALSO LIKE:

Learn How To Time The Market With IBD's ETF Market Strategy

Find Today's Best Growth Stocks To Watch With IBD 50

Find The Best Long-Term Investments With IBD Long-Term Leaders

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2494352670"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2494352670\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2494352670?lang=zh_CN&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU77-150x150.jpg","is_english":true,"pubTime":"2024-12-28 03:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2494352670","market":"us","top_or_hot":-1,"title":"Arcellx Stock Earns 82 Relative Strength Rating","media":"Blockhead","content":"<html><body><div>\n<p><b>Arcellx</b> (ACLX) stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 79 to 82.</p>\n<span>\n<span>\n<span jw-video-key=\"ULpM3j8K\" vid-authors=\"MEREDITH HEYMAN\" vid-cat=\"IBD Explains\" vid-date=\"12/17/2024\" vid-date-tmsp=\"1734424574\" vid-dom-id=\"9579501-676f3d3fc8c34\" vid-id=\"9579501\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/12/ULpM3j8K-640x360.jpg\" vid-name=\"This Is How A New President Will Impact Fed Rate Cuts In 2025\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/ULpM3j8K.m3u8\" vid-width=\"50\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span></span>\n<div>\n<div>\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n</div>\n<div>\nSee All Videos\n</div>\n</div>\n</span>\n<span>\n<span>NOW PLAYING</span>\n<span>This Is How A New President Will Impact Fed Rate Cuts In 2025</span>\n</span>\n</span>\n</span>\n</span>\n<p>This exclusive rating from Investor's Business Daily identifies share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.</p>\n<p>Decades of market research shows that the market's biggest winners typically have an 80 or higher RS Rating in the early stages of their moves.</p>\n<hr/>\n<p>Hone Your Stock-Picking Skills By Focusing On These Factors</p>\n<hr/>\n<h2>Is Arcellx Stock A Buy?</h2>\n<p>Arcellx stock is now considered extended and out of buy range after clearing a 74.09 buy point in a fourth-stage cup with handle. See if the biotech stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.</p>\n<div><div></div></div>\n<p>The Calif.-based biotech company reported 0% earnings growth in the latest quarterly report, while sales growth came in at 74%.</p>\n<p>Arcellx stock holds the No. 111 rank among its peers in the Medical-Biomed/Biotech industry group. <b>Catalyst Pharmaceuticals</b> (CPRX), <b>ADMA Biologics</b> (ADMA) and <b>Exelixis</b> (EXEL) are among the top 5 highly rated stocks within the group. For more industry news, check out \"Biotech And Pharmaceutical Industry And Stock News.\"</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p><span>Learn How To Time The Market With IBD's ETF Market Strategy</span></p>\n<p><span>Find Today's Best Growth Stocks To Watch With IBD 50</span></p>\n<p><span>Find The Best Long-Term Investments With IBD Long-Term Leaders</span></p>\n<p><span>How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks</span></p>\n</div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arcellx Stock Earns 82 Relative Strength Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArcellx Stock Earns 82 Relative Strength Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-28 03:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/arcellx-stock-earns-82-relative-strength-rating/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Arcellx (ACLX) stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 79 to 82.\n\n\n\n↑\nX\n\n\n\n\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n\n...</p>\n\n<a href=\"https://www.investors.com/news/arcellx-stock-earns-82-relative-strength-rating/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RS","symbol_name":"Reliance Steel & Aluminum Co","start_time":0,"source_url":"https://www.investors.com/news/arcellx-stock-earns-82-relative-strength-rating/","article_id":"2494352670","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU77-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2494352670","pubTimestamp":1735326540,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Arcellx shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RS":"Reliance Steel & Aluminum Co","EXEL":"伊克力西斯","BK4532":"文艺复兴科技持仓","BK4006":"钢铁","BK4139":"生物科技","ADMA":"ADMA Biologics Inc","CPRX":"Catalyst Pharmaceutical Partners","ACLX":"ARCELLX, INC."},"translate_title":"Arcellx股票获得82相对强度评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACLX":1,"ADMA":1,"CPRX":1,"EXEL":1,"RS":1},"content_text":"Arcellx (ACLX) stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 79 to 82.\n\n\n\n↑\nX\n\n\n\n\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n\n\n\n\nThis exclusive rating from Investor's Business Daily identifies share price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.\nDecades of market research shows that the market's biggest winners typically have an 80 or higher RS Rating in the early stages of their moves.\n\nHone Your Stock-Picking Skills By Focusing On These Factors\n\nIs Arcellx Stock A Buy?\nArcellx stock is now considered extended and out of buy range after clearing a 74.09 buy point in a fourth-stage cup with handle. See if the biotech stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.\n\nThe Calif.-based biotech company reported 0% earnings growth in the latest quarterly report, while sales growth came in at 74%.\nArcellx stock holds the No. 111 rank among its peers in the Medical-Biomed/Biotech industry group. Catalyst Pharmaceuticals (CPRX), ADMA Biologics (ADMA) and Exelixis (EXEL) are among the top 5 highly rated stocks within the group. For more industry news, check out \"Biotech And Pharmaceutical Industry And Stock News.\"\nYOU MAY ALSO LIKE:\nLearn How To Time The Market With IBD's ETF Market Strategy\nFind Today's Best Growth Stocks To Watch With IBD 50\nFind The Best Long-Term Investments With IBD Long-Term Leaders\nHow To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}